Edward Miller - 14 Nov 2022 Form 4 Insider Report for Allovir, Inc. (KLRS)

Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
KLRS
Transactions as of
14 Nov 2022
Net transactions value
-$21,018
Form type
4
Filing time
16 Nov 2022, 16:10:33 UTC
Previous filing
26 Oct 2022
Next filing
23 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale $21,018 -2,358 -1.2% $8.91 190,453 14 Nov 2022 See Footnote F1, F2, F3
holding ALVR Common Stock 249,377 14 Nov 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 26, 2022.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.90 to $8.94. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 Shares held by The Miller Family 2019 Irrevocable Dynasty Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.